SE7812207A - Apparatus, method, and framstellda products for priority over the administration of antihistamines - Google Patents

Apparatus, method, and framstellda products for priority over the administration of antihistamines

Info

Publication number
SE7812207A
SE7812207A SE7812207A SE7812207A SE7812207A SE 7812207 A SE7812207 A SE 7812207A SE 7812207 A SE7812207 A SE 7812207A SE 7812207 A SE7812207 A SE 7812207A SE 7812207 A SE7812207 A SE 7812207A
Authority
SE
Sweden
Prior art keywords
antihistamine
framstellda
antihistamines
administration
products
Prior art date
Application number
SE7812207A
Other languages
Swedish (sv)
Inventor
S G Nogrady
Original Assignee
Welsh Nat School Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB5002077 priority Critical
Application filed by Welsh Nat School Med filed Critical Welsh Nat School Med
Publication of SE7812207A publication Critical patent/SE7812207A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/826Asthma

Abstract

An antihistamine of the benzhydrylether, alkylamine, or benzocyloheptatiophene class is suitable for use in the therapeutic treatment or prophylaxis of reversible airways obstruction by inhalation. The antihistamine may be clemastine, chlorpheniramine or ketotifen and may be in the form of a composition in admixture with a diluent. The antihistamine can be administered from a pharmaceutical inhalation device which is designed to administer a dosage unit of the antihistamine. The inhalation device can be in the form of a pressurized aerosol inhaler or a dry powder insufflator.
SE7812207A 1977-12-01 1978-11-27 Apparatus, method, and framstellda products for priority over the administration of antihistamines SE7812207A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB5002077 1977-12-01

Publications (1)

Publication Number Publication Date
SE7812207A true SE7812207A (en) 1979-06-02

Family

ID=10454354

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7812207A SE7812207A (en) 1977-12-01 1978-11-27 Apparatus, method, and framstellda products for priority over the administration of antihistamines

Country Status (5)

Country Link
US (1) US4232002A (en)
AU (1) AU4213878A (en)
DE (1) DE2851543A1 (en)
FR (1) FR2414913A1 (en)
SE (1) SE7812207A (en)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5340587A (en) * 1985-05-22 1994-08-23 Liposome Technology, Inc. Liposome/bronchodilator method & System
EP0223831B1 (en) * 1985-05-22 1992-07-15 Liposome Technology, Inc. Liposome inhalation method and system
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
SE9404468D0 (en) * 1994-12-22 1994-12-22 Astra Ab Powder Formulations
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
MY131733A (en) 1994-12-22 2007-08-30 Astra Ab Aerosol drug formulations
AT238043T (en) * 1994-12-22 2003-05-15 Astrazeneca Ab Parathyroid hormone PTH-containing therapeutic formulation for inhalation
DE69732412T2 (en) * 1996-04-12 2006-01-05 Novadel Pharma Inc. Bukales polar spray
US5798388A (en) * 1996-09-06 1998-08-25 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
US5770618A (en) * 1996-11-13 1998-06-23 Nastech Pharmaceutical Company, Inc. Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
EP1036561A1 (en) * 1997-10-01 2000-09-20 Flemington Pharmaceutical Corporation Buccal, non-polar spray
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
WO2002094245A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of antihistamines through an inhalation route
EP1392262A1 (en) 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
EP1625333A1 (en) 2003-05-21 2006-02-15 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2767163A1 (en) 2005-02-17 2014-08-20 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
WO2007123955A2 (en) * 2006-04-19 2007-11-01 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
CA2673049C (en) * 2006-12-22 2016-02-23 Novadel Pharma Inc. Stable anti-nausea oral spray formulations and methods
BRPI0811430A2 (en) * 2007-05-10 2015-06-23 Novadel Pharma Inc anti-insomnia compositions and processes
US20090203763A1 (en) * 2008-01-22 2009-08-13 Auspex Pharmaceuticals, Inc. Substituted benzhydrylethers

Also Published As

Publication number Publication date
US4232002A (en) 1980-11-04
AU4213878A (en) 1979-06-07
FR2414913A1 (en) 1979-08-17
DE2851543A1 (en) 1979-06-07

Similar Documents

Publication Publication Date Title
Lipton et al. Human ingestion of a'superwarfarin'rodenticide resulting in a prolonged anticoagulant effect
IT1061751B (en) A process for the production of pharmaceutical compounds particularly suitable for the treatment of diseases of the heart and of the circulatory system
AU528190B2 (en) Device for oral administration of drugs to ruminant animals
ES2181673T3 (en) Process for treating infectious respiratory disease.
SE8704767D0 (en) New Method for Drug Administration
NO934499A (en) Non-klorfluorcarbonaerosolformuleringer
YU49495B (en) Controlled release oxycodone formulation and their use
NO145709C (en) Inhaler with at least two movable parts for the dispensing of powdered medicaments
ATA84882A (en) Therapeutic delivery system for administration of an active ingredient through the skin
SK285910B6 (en) Medical product comprising a combination of formoterol and budesonide
NO333292B1 (en) Topical pharmaceutical formulations and the use of a therapeutic agent for the preparation of such
MX9302160A (en) Pharmaceutical compositions of interferon of human Cocito leu concordant.
SE8402550L (en) N-substituted deridvat of moranoline
NO309360B1 (en) Stabilized solid dosage form with controlled release of a dose of a therapeutically active agent and process for preparation thereof
BR0108730A (en) System, apparatus and method for administering a drug, the nozzle of a drug delivery device, the device for delivering multiple unit doses of a drug, methods for preparing a drug delivery system is a drug formulation and treatment a patient requiring multiple doses of a drug, drug formulation and multiparticulates
MX9206588A (en) Syringe to administer liquid and semiliquid compositions.
CZ281913B6 (en) pharmaceutical preparation for treating or prevention of loss of bone mass in humans and use thereof
IL92700D0 (en) Method for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the cervicular pocket,composition of matter therefor and apparatus for the administration thereof
CZ281509B6 (en) Novel esters of bi- and tricyclic aminoalcohols, process for preparing thereof and pharmaceutical preparations in which they are comprised
NO924209A (en) Dosage Form for tilfoersel of an anti-parkinsonian agent
DK0532641T3 (en) Pre-filled disposable device for introducing a pharmacologically active substance in a body cavity of a patient, a method for the preparation of the device as well as the casting apparatus for producing the device
RO119066B1 (en) Oral pharmaceutical composition and method for treating parkinson's disease using said composition
NO20065102A (en) drugs
DK132012C (en) An apparatus for delivery of a particulate medicament in a body cavity
ES2162927T3 (en) Formulation for administration by inhalation.